GEORGE KARFUNKEL
CIK 1085765 · last filed 2021-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.03M
Companies
5
Total Filings
38
Lifetime Open-Market Net
$68.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KODK | Director | 4,490,145 | $8.47 | $38.03M | $10.09M | 11 | 2021-05-20 |
| Amtrust Financial Services, Inc. (AFST) Delisted | Director | 0 | — | — | $4.44M | 3 | 2018-12-03 |
| EASTMAN KODAK CO (KODK.WS.A) Delisted | Director | 2,213,180 | — | — | $8.98M | 9 | 2018-01-10 |
| Amtrust Financial Services, Inc. (AFSI) Delisted | Director | 31,958,408 | — | — | $44.52M | 9 | 2015-03-24 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | 10%+ Owner | 4,982,217 | — | — | $0 | 3 | 2010-05-11 |
Recent Filings · Page 4 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-09-12 | — | Buy (P) | +3,434,922 | $38.51M | |
| 2013-06-05 | Amtrust Financial Services, Inc. (AFSI) Delisted | Buy (P) | +1,000,000 | $25.00M | EDGAR |
| 2012-11-06 | Amtrust Financial Services, Inc. (AFSI) Delisted | Gift (G) | −400,000 | $0 | EDGAR |
| 2010-05-11 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Exer (X) | — | $0 | EDGAR |
| 2009-08-24 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +285,715 | $0 | EDGAR |
| 2009-07-14 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +1,100,000 | $0 | EDGAR |
| 2008-02-05 | Amtrust Financial Services, Inc. (AFSI) Delisted | Gift (G) | −1,150,000 | $0 | EDGAR |
| 2007-11-27 | Amtrust Financial Services, Inc. (AFSI) Delisted | — | — | $0 | EDGAR |
Showing 31–38 of 38
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.